Nearly 700,000 women are to be recruited to take part in an NHS artificial intelligence (AI) breast cancer screening trial in England.Five different AI platforms will be tested across 30 sites from April to see if the technology can speed up diagnosis as well as free up radiologists.

Health Secretary Wes Streeting, who survived kidney cancer in 2021, is launching an NHS-wide breast cancer trial using artificial intelligence to analyse mammograms

NHS clinics will use artificial intelligence to screen for breast cancer in a massive “landmark” trial. Almost 700,000 British women are expected to take part in a study of using algorithms to

The NHS is launching the world's biggest trial of AI to detect breast cancer, screening two-thirds of 700,000 women. Five different types of AI will read about 462,000 mammograms at 30 breast cancer screenings later. The other 238,000 will be read in the usual way by two radiologists.

New technology, which hundred of thousands of women will be invited to help test over the coming months, could improve diagnoses while also lessening demands on radiologists, according to DHSC Hundred

Health chiefs have announced the biggest rollout of artificial intelligence in the NHS in an attempt to speed up breast cancer diagnosis.

A major trial aiming to transform breast cancer screening with artificial intelligence has been launched, with almost 700,000 women expected to take part.

AI tools like the ones being tested in the EDITH trial could help facilitate the screening process, allowing the NHS to manage its resources better. With around 2.1 million mammogram screenings carried out annually, AI could significantly reduce the time required for each screening, making the system more efficient.

A North Yorkshire hospital has introduced AI technology that could speed up the detection of lung cancer and other serious illnesses. Harrogate and District NHS Foundation Trust said the software would "significantly improve" the efficiency and accuracy of chest X-ray analysis.